September 1, 2017 / 7:14 PM / a year ago

Insys rejects Arizona AG's claims drugmaker fueled opioid crisis

Insys Therapeutics Inc on Friday disputed the assertion by the Arizona attorney general that it fueled an opioid addiction epidemic in the state by fraudulently marketing a fentanyl-based drug, saying those claims “lack context and factual accuracy.”

The Chandler, Arizona-based drugmaker issued a lengthy statement after Arizona Attorney General Mark Brnovich filed a lawsuit on Thursday against Insys over its marketing of a cancer pain treatment called Subsys.

To read the full story on WestlawNext Practitioner Insights, click here:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below